| Pipeline | Class | Target | Type | Early Dev | PD/PK | CMC | IND | Clinical Study | Status |
| FTL001 | FIC | 4-1BB | mAb |
|
Phase Ⅰ | ||||
|---|---|---|---|---|---|---|---|---|---|
| FTL004 | BIC | CD38 | mAb |
|
IND Approved | ||||
| FTL008.16 | FIC | undisclosed | BsAb |
|
IND Filed | ||||
| FTL008.7 | FIC | undisclosed | BsAb |
|
|||||
| FTL012 | FIC | undisclosed | mAb |
|
|||||
| FTL018 | FIC | undisclosed | mAb |
|
|||||
| FTL016 | FIC | undisclosed | mAb |
|
|||||
| FTL008.17 | FIC | 4-1BB/TAA | BsAb |
|
|||||
| FTL008.18 | FIC | cytokine/TAA | BsAb |
|
|||||
